海南矿业股份有限公司重大资产重组进展公告——拟收购洛阳丰瑞氟业69.90%股权
要点摘要
- 收购方案： 海南矿业股份有限公司（下称“海南矿业”）计划通过发行股份及支付现金的方式，向王中喜、王琛及上海柏帝投资管理有限公司（下称“柏帝投资”）三方购买其合计持有的洛阳丰瑞氟业有限公司（下称“丰瑞氟业”）69.90%的股权。
- 配套融资： 公司拟向不超过35名特定投资者发行股份，募集配套资金，用于本次交易。
- 审批事项： 本次收购标的资产不涉及立项、环保、行业准入、用地、规划、建设施工等需报批事项。
- 合规性及风险披露： 所有相关法律程序和先决条件得到满足的前提下，股权过户或转让不存在限制或禁止转让情况。公司已在报告书中披露相关审批程序及提示审批风险。
- 资产完整性与独立性： 通过本次交易，公司将获得生产经营所需的商标权、专利权、非专利技术、采矿权、特许经营权等无形资产，有利于保障公司在人员、采购、生产、销售、知识产权等方面的独立性。
- 持续经营能力提升： 公司认为此次收购有助于增强持续经营能力、突出主业、提升抗风险能力，并不会导致财务状况出现重大不利变化或引发重大不利影响的同业竞争、严重影响独立性或显失公平的关联交易。
- 时间节点： 公告时间为2026年5月9日。
对股东和投资者的重要影响及潜在股价影响因素
- 并购对象为氟化工企业： 丰瑞氟业是一家专注于氟化工领域的企业，氟化工作为新材料及新能源等下游产业链的重要环节，近年来行业景气度持续提升。海南矿业本次收购有望拓展公司业务版图，增加盈利点，提升公司整体估值。
- 增强公司独立性与抗风险能力： 取得丰瑞氟业控股权后，公司将在人员、采购、生产、销售、知识产权等环节实现更高的自主性，有助于构建更完整的业务体系。
- 不存在重大合规障碍： 本次交易不涉及重大审批障碍，且相关股权不存在出资不实或影响合法存续的情况，降低收购失败风险。
- 不会导致同业竞争或严重影响独立性： 交易完成后，公司主营业务更加突出，不会新增重大不利影响的同业竞争或不公平的关联交易。
- 潜在股价催化剂： 若收购顺利完成，有望成为公司业绩和估值提升的催化剂，吸引更多市场关注和资金流入。
- 风险提示： 公司已特别提示审批事项存在不确定性，投资者需关注后续公告。
详细内容
海南矿业股份有限公司董事会于2026年5月9日发布公告，披露其拟通过发行股份及支付现金的方式，向三位交易对方合计购买洛阳丰瑞氟业有限公司69.90%股权，并计划向不超过35名特定投资者发行股份募集配套资金。本次交易方案已在公司披露的草案中详细说明，并明确指出标的资产不涉及立项、环保、行业准入、用地、规划、建设施工等报批事项。
董事会指出，标的资产不存在出资不实或影响合法存续的情况，股权过户不存在法律障碍。在交易完成后，公司将进一步提升资产完整性，获得生产经营所需的无形资产和资源，有助于增强公司在各环节的独立性和自主性。
此外，公司强调本次收购有利于提升持续经营能力和抗风险能力，不会引发重大财务风险或同业竞争，也不会导致重大不公平的关联交易。董事会认为，本次交易符合中国证监会相关监管指引，有助于公司健康可持续发展。
投资者关注要点
- 此次并购涉及氟化工优质资产，为公司业务拓展及市值提升带来新机遇。
- 本次交易的顺利推进有望成为公司业绩和估值提升的催化剂。
- 需持续关注相关审批进展及收购后业绩整合情况。
- 相关风险（如审批未通过）仍需投资者保持警惕。
【免责声明】本文内容仅供参考，不构成任何投资建议。投资者应结合公司公告及自身风险承受能力，谨慎决策。公司后续进展及相关信息请以官方公告为准。
Hainan Mining Co., Ltd. Announces Major Asset Restructuring: Proposed Acquisition of 69.90% Equity in Luoyang Fengrui Fluorine Industry
Key Highlights
- Acquisition Plan: Hainan Mining Co., Ltd. (hereinafter referred to as “Hainan Mining”) plans to acquire 69.90% equity of Luoyang Fengrui Fluorine Industry Co., Ltd. (“Fengrui Fluorine”) from three parties—Wang Zhongxi, Wang Chen, and Shanghai Baidi Investment Management Co., Ltd.—through a combination of share issuance and cash payment.
- Supporting Financing: The company will issue shares to no more than 35 specific investors to raise supporting funds for the transaction.
- Approval Matters: The acquisition does not involve government project approval, environmental protection, industry access, land use, planning, or construction-related reporting matters.
- Compliance and Risk Disclosure: Provided all legal procedures and prerequisites are fulfilled, there are no restrictions or prohibitions on the transfer of the relevant equity. The company has disclosed approval procedures and highlighted related approval risks in its report.
- Asset Integrity and Independence: The transaction will enable the company to obtain trademarks, patents, non-patent technologies, mining rights, franchise rights, and other intangible assets necessary for business operations, enhancing independence in staffing, procurement, production, sales, and IP management.
- Enhanced Business Continuity: The board believes the acquisition will strengthen the company’s ability to operate continuously, highlight its core business, improve risk resistance, and will not cause major adverse changes to its financial condition or introduce unfair related-party transactions or significant industry competition.
- Timeline: Announcement dated May 9, 2026.
Key Points for Shareholders and Potential Share Price Impact
- Acquisition Target in Fluorine Chemical Industry: Fengrui Fluorine focuses on fluorochemical products, a key segment in the new materials and new energy sectors. The acquisition could expand Hainan Mining’s business footprint, add new profit drivers, and potentially raise the company’s valuation.
- Increased Independence and Risk Resistance: With control of Fengrui Fluorine, the company will gain higher autonomy in personnel, procurement, production, sales, and IP, building a more complete business system.
- No Major Compliance Barriers: There are no significant legal or regulatory barriers for this acquisition, and the equity to be acquired is clear of any capital inadequacy or legal existence issues, reducing the risk of deal failure.
- No New Major Industry Competition or Related-Party Risks: The acquisition will make the company’s main business more focused and will not introduce significant competition or unfair related-party transactions.
- Potential Share Price Catalyst: Successful completion of the acquisition may drive performance and valuation, attracting market attention and capital inflows.
- Risk Warning: The company has specifically highlighted approval risks; investors should monitor further announcements.
Details
On May 9, 2026, the board of Hainan Mining announced its plan to acquire a controlling stake (69.90%) in Luoyang Fengrui Fluorine Industry via a combination of share issuance and cash payment, and to raise supporting funds by issuing shares to up to 35 specific investors. The plan has been detailed in the company’s draft report, highlighting that the transaction does not involve project, environmental, industry access, land, planning, or construction approval matters.
The board confirmed that the target asset is free from capital inadequacy or legal existence risks, and that there are no legal obstacles to the equity transfer. Upon completion, the acquisition will improve asset integrity and give the company access to trademarks, patents, non-patented technologies, mining rights, and franchise rights, thereby enhancing independence and autonomy in all operational aspects.
Additionally, the acquisition is expected to improve the company’s ability to operate continuously and resist risks, without causing significant adverse financial effects or introducing major industry competition or unfair related-party transactions. The board considers the transaction compliant with relevant regulatory guidelines and conducive to healthy, sustainable growth.
Takeaways for Investors
- This acquisition involves a quality asset in the fluorine chemical sector, which could offer new growth and valuation opportunities for the company.
- Progress on this transaction could serve as a catalyst for the company’s performance and share price.
- Investors should pay attention to further approvals and post-acquisition integration performance.
- Risks such as approval uncertainties remain; investors are advised to remain cautious.
[Disclaimer] The above content is for reference only and does not constitute investment advice. Investors should refer to official company announcements and evaluate their own risk tolerance before making decisions. Please rely on official disclosures for further updates and details.
